Grifols Expands Global Reach With New Treatment Facility

Verkkothe transaction bolsters grifols’ standing as a global leader in fractionation capacity (20 million liters plasma/year) and operator of europe’s largest.

Verkkolocated in the va building at the umass chan medical school campus in worcester, mass. , grifols' new biomat usa donor center joins the.

Verkkothe flagship grifols campus is a touchstone of grifols’ leadership in plasma therapeutics, producing about 40% of the company’s total medicinal output.

Verkkothe new plant further reflects grifols investment in europe and expands its current global capacity to meet rising demand for plasma medicines.